Literature DB >> 20662554

Association of matrix metalloproteinases 1, 7, and 9 gene polymorphisms with genetic susceptibility to colorectal carcinoma in a Han Chinese population.

Wen-Liang Fang1, Wei-Bo Liang, Huan He, Yi Zhu, Shi-Liu Li, Lin-Bo Gao, Lin Zhang.   

Abstract

Matrix metalloproteinases (MMPs) play an important role in colorectal cancer (CRC). Accumulated evidence suggests an association between MMP-1, MMP-7, and MMP-9 functional gene polymorphisms with several tumors. The aim of this study was to investigate the association of single-nucleotide polymorphism (SNP) at MMP-1 16071G/2G, MMP-7 181A/G, and MMP-9 279R/Q genes with CRC in the southwest Chinese Han population. The study used 237 CRC patients and 252 normal control matched by age and sex from Sichuan province in China. Samples were genotyped using both polymerase chain reaction-restriction fragment length polymorphism and DNA sequencing. We found significant differences in the genotype and allele frequency of MMP-9 279 R/Q between the case and control group. Individuals who carried MMP-9 279 R allele were more susceptible to CRC (odds ratio = 1.737, 95% confidence interval = 1.323-2.281, p < 0.001). Moreover, the RR genotype of MMP-9 279 R/Q was associated with an increased risk of CRC compared with the QQ genotype (odds ratio = 2.213, 95% confidence interval = 1.248-3.926, p = 0.006). However, there were no significant differences in the genotype and allele frequency of the MMP-1 16071G/2G and MMP-7 181 A/G between the case and control group, and the latter may be due to lower minor allele frequency. The MMP-9 279R/Q alleles and genotypes may be associated with the risk of CRC in Han Chinese.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20662554     DOI: 10.1089/dna.2010.1017

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  8 in total

1.  Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.

Authors:  Alexandra Mj Langers; Hein W Verspaget; Daniel W Hommes; Cornelis Fm Sier
Journal:  World J Gastrointest Oncol       Date:  2011-06-15

2.  Prognostic value of matrix metalloproteinase-1/ proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma.

Authors:  Mingmei Liao; Ping Tong; Jinfeng Zhao; Yangde Zhang; Zhehai Li; Jiwei Wang; Xueping Feng; Man Hu; Yifeng Pan
Journal:  Pathol Oncol Res       Date:  2011-09-10       Impact factor: 3.201

Review 3.  Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.

Authors:  Xiaoying Li; Lianxi Qu; Yu Zhong; Yingjie Zhao; Hongyan Chen; Lu Daru
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-05       Impact factor: 4.553

Review 4.  Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.

Authors:  Sugreev Verma; Kousik Kesh; Nilanjan Ganguly; Sayantan Jana; Snehasikta Swarnakar
Journal:  World J Biol Chem       Date:  2014-08-26

5.  A/G polymorphism of matrix metalloproteinase 7 gene promoter region and cancer risk: A meta-analysis.

Authors:  Jing Wu; Xuan Guan; Kui Zhang; Ya-Ting Li; Peng Bai; Jin Wu
Journal:  Biomed Rep       Date:  2013-07-11

6.  The association between individual SNPs or haplotypes of matrix metalloproteinase 1 and gastric cancer susceptibility, progression and prognosis.

Authors:  Yong-Xi Song; Xin Zhou; Zhen-Ning Wang; Peng Gao; Ai-Lin Li; Ji-Wang Liang; Jin-Liang Zhu; Ying-Ying Xu; Hui-Mian Xu
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

7.  ASSOCIATION OF MMP-7 -181A>G POLYMORPHISM WITH COLORECTAL CANCER AND GASTRIC CANCER SUSCEPTIBILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Authors:  Mohammad Zare; Jamal Jafari-Nedooshan; Kazem Aghili; Hossein Ahrar; Mohammad Hossein Jarahzadeh; Neda Seifi-Shalamzari; Masoud Zare-Shehneh; Hossein Neamatzadeh
Journal:  Arq Bras Cir Dig       Date:  2019-10-21

Review 8.  Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer.

Authors:  Zahra Pezeshkian; Stefania Nobili; Noshad Peyravian; Bahador Shojaee; Haniye Nazari; Hiva Soleimani; Hamid Asadzadeh-Aghdaei; Maziar Ashrafian Bonab; Ehsan Nazemalhosseini-Mojarad; Enrico Mini
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.